Risk group stratification in patients undergoing permanent 125I prostate brachytherapy as monotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk group stratification in patients undergoing permanent 125I prostate brachytherapy as monotherapy

Published:2002-07 Issue:3 Volume:53 Page:588-594
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kwok Young,DiBiase Steven J,Amin Pradip P,Naslund Michael,Sklar Geoffrey,Jacobs Stephen C

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life;Walsh;J Urol,2000

2. Dose escalation with 3D conformal treatment;Hanks;Int J Radiat Oncol Biol Phys,1998

3. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer;Merrick;Int J Radiat Oncol Biol Phys,2001

4. 10-Year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy;Grimm;Int J Radiat Oncol Biol Phys,2001

5. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma;Wallner;J Clin Oncol,1996

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic resonance imaging in prostate brachytherapy: Evidence, clinical end points to data, and direction forward;Brachytherapy;2017-07

2. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer;Brachytherapy;2017-03

3. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy;Brachytherapy;2013-05

4. Biochemical control of prostate cancer with iodine-125 brachytherapy alone: experience from a single institution;Clinical and Translational Oncology;2012-05

5. Current Status of Brachytherapy for Prostate Cancer;Korean Journal of Urology;2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3